HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Locally instilled tumor necrosis factorantisense oligonucleotide inhibits allergic inflammation via the induction of Tregs.

AbstractBACKGROUND:
Anti-tumor necrosis factor (TNF)-α therapeutics has the potential to alleviate allergic inflammation. However, in previous studies, the systemic administration of anti-TNF-α agents was frequently accompanied by many adverse effects, such as infection, immunogenicity and malignancy. Efforts are made in the present study to evaluate whether or not local administration of TNF-α antisense oligonucleotide would inhibit allergic airway inflammation and influence systemic immune responses in an ovalbumin-induced asthmatic murine model.
METHODS:
The treatment effects of TNF-α antisense oligonucleotide on mice, as well as the alternative proportion of regulatory T cells and T(H) 2 cells, were examined and compared with untreated mice.
RESULTS:
Local administration of TNF-α antisense oligonucleotide resulted in significantly inhibited TNF-α expression, remarkably decreased inflammatory cell infiltration and dramatically reduced mucus hypersecretion. These treatment effects were associated with induced CD4(+) CD25(+) Foxp3(+) regulatory T cells, reduced T(H) 2 cells and generally decreased T(H) 2-type cytokines expression in bronchoalveolar lavage fluid. Systemic immunosuppression was not triggered by local antisense oligonucleotide administration because the proportion of CD4(+) CD25(+) Foxp3(+) regulatory T cells in the blood, thymus or spleen was not affected. Attenuated 4-1BBL expression was likely involved in the alternative proportion of T cells.
CONCLUSIONS:
These findings demonstrate that local administration of TNF-α antisense oligonucleotide contributes to anti-inflammatory action via the enhancement of regulatory T cells-mediated immune tolerance, which is not accompanied by systemic immunosuppression associated with systemically-induced regulatory T cells.
AuthorsYi Luo, Zhonghua Pang, Qian Zhu, Xing Cai, Yuan Yin, Min Wang, Jie Zhu, Jiangning Chen, Ke Zeng, Chenyu Zhang, Junfeng Zhang
JournalThe journal of gene medicine (J Gene Med) Vol. 14 Issue 6 Pg. 374-83 (Jun 2012) ISSN: 1521-2254 [Electronic] England
PMID22576979 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 John Wiley & Sons, Ltd.
Chemical References
  • CD3 Complex
  • CD4 Antigens
  • CD8 Antigens
  • Forkhead Transcription Factors
  • Foxp3 protein, mouse
  • Interleukin-2 Receptor alpha Subunit
  • Oligonucleotides, Antisense
  • Tumor Necrosis Factor-alpha
  • Ovalbumin
Topics
  • Animals
  • Asthma (chemically induced, therapy)
  • Bronchoalveolar Lavage Fluid (chemistry, immunology)
  • CD3 Complex (biosynthesis)
  • CD4 Antigens (biosynthesis)
  • CD8 Antigens (biosynthesis)
  • Female
  • Forkhead Transcription Factors (biosynthesis)
  • Inflammation (therapy)
  • Interleukin-2 Receptor alpha Subunit (biosynthesis)
  • Lung (immunology, metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Oligonucleotides, Antisense (administration & dosage, metabolism, pharmacology)
  • Ovalbumin
  • T-Lymphocytes, Regulatory (immunology)
  • Th2 Cells (immunology)
  • Tumor Necrosis Factor-alpha (biosynthesis, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: